Description

GLP-2 (Tirzepatide) is a synthetic 39-amino acid peptide engineered as a dual agonist of both the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor. Each vial contains 10mg of high-purity lyophilized compound, synthesized using advanced methods and verified through independent third-party analysis.

Specifications:
• Product Name: GLP-2 (Tirzepatide)
• CAS Number: 2023788-19-2
• Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈
• Molecular Weight: ~4813.45 g/mol
• Quantity: 10mg per vial
• Form: Lyophilized (freeze-dried) powder
• Purity: ≥99% (HPLC verified)
• Testing Methods: HPLC, Mass Spectrometry
• Appearance: White to off-white powder
• Origin: USA sourced & shipped
• COA: Included with every order

Storage & Handling:
• Lyophilized (unopened): Store at −20°C for long-term stability. Short-term storage at 2–8°C is acceptable.
• Reconstituted solution: Refrigerate at 2–8°C, protect from light, and use within the recommended timeframe.
• Avoid repeated freeze-thaw cycles. Handle in accordance with institutional safety guidelines.

Research Applications:
Tirzepatide is utilized in research settings investigating dual GIP/GLP-1 receptor agonism, incretin signaling pathways, and metabolic mechanisms. This compound supports researchers studying receptor selectivity, binding kinetics, and peptide pharmacology in controlled laboratory environments.